Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Public Float

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Public Float

Insight Molecular Diagnostics Inc. (IMDX) had Public Float of $32.40 million as of 2025-06-30, per its 10-K filed 2026-03-26.

Financial Statements › Notes › Cover Page

dei:EntityPublicFloat · last filed 2026-03-26

  • 2025-06-30: Entity Public Float $32.40M.
  • 2024-06-30: Entity Public Float $24.60M.
  • 2023-06-30: Entity Public Float $18.80M.
  • 2022-06-30: Entity Public Float $68.50M.
Period endEntity Public Float
2025-06-30$32.40M
10-K · filed 2026-03-26
2024-06-30$24.60M
10-K · filed 2025-03-24
2023-06-30$18.80M
10-K · filed 2024-04-16
2022-06-30$68.50M
10-K/A · filed 2023-05-01
2021-06-30$297.60M
10-K/A · filed 2022-05-02
2020-06-30$70.30M
10-K · filed 2021-03-19
2019-06-30$47.00M
10-K · filed 2020-03-26
2018-06-30$27.60M
10-K · filed 2019-04-01
2017-06-30$41.40M
10-K · filed 2018-04-02
2016-06-30$14.70M
10-K · filed 2017-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92